MED26

From Wikipedia, the free encyclopedia
(Redirected from MED26 (gene))
MED26
Identifiers
AliasesMED26, CRSP7, CRSP70, mediator complex subunit 26
External IDsOMIM: 605043 MGI: 1917875 HomoloGene: 68417 GeneCards: MED26
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_004831

NM_027485

RefSeq (protein)

NP_004822

NP_081761

Location (UCSC)Chr 19: 16.57 – 16.63 MbChr 8: 73.25 – 73.3 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Med26
solution structure of the n-terminal domain i of mouse transcription elongation factor s-ii protein 3
Identifiers
SymbolMed26 N-terminal domain
PfamPF08711
InterProIPR017923
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary
Mediator subunit 26 Middle domain
Identifiers
SymbolMed26_M
PfamPF15694
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary
Mediator subunit 26 C-terminal domain
Identifiers
SymbolMed26_C
PfamPF15693
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary

Mediator of RNA polymerase II transcription subunit 26 is an enzyme that in humans is encoded by the MED26 gene.[5][6] It forms part of the Mediator complex.

The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors.[6]

Activity[edit]

MED26 is a transcription elongation factor that increases the overall transcription rate of RNA polymerase II by reactivating transcription elongation complexes that have arrested transcription. It does this through recruiting ELL/EAF- and P-TEFb- containing complexes to promoters via a direct interaction with the N-terminal domain (NTD). The MED26 NTD also binds TFIID, and TFIID and elongation complexes interact with MED26 through overlapping binding sites.[7] MED26 NTD may function as a molecular switch contributing to the transition of Pol II into productive elongation.

The three structural domains of TFIIS are conserved from yeast to human. The 80 or so N-terminal residues form a protein interaction domain containing a conserved motif, which has been called the LW motif because of the invariant leucine and tryptophan residues it contains. Although the N-terminal domain is not needed for transcriptional activity, a similar sequence has been identified in other transcription factors and proteins that are predominantly nuclear localized.[8][9][10] Specific examples are listed below:

  • MED26 (also known as CRSP70 and ARC70), a subunit of the Mediator complex, which is required for the activity of the enhancer-binding protein Sp1.
  • Elongin A, a subunit of a transcription elongation factor previously known as SIII. It increases the rate of transcription by suppressing transient pausing of the elongation complex.
  • PPP1R10, a nuclear regulatory subunit of protein phosphatase 1 that was previously known as p99, FB19 or PNUTS.
  • PIBP, a small hypothetical protein that could be a phosphoinositide binding protein.
  • IWS1, which is thought to function in both transcription initiation and elongation.[11]
  • TFIIS, which rescues RNA polymerase II from backtracked pause states.

The N-terminal domain of MED26 is a protein fold known as a TFIIS N-terminal domain (or TND).[8] It is a compact five-helix bundle. The hydrophobic core residues of helices 2, 3, and 4 are well conserved among TFIIS domains, although helix 1 is less conserved.[10]

Interactions[edit]

MED26 has been shown to interact with MED8,[12] Cyclin-dependent kinase 8,[12] POLR2A,[12] MED12[12] and MED28.[12] It also acts synergistically to mediate the interaction between REST (a Kruppel-type zinc finger transcription factor that binds to a 21-bp RE1 silencing element present in over 900 human genes) and Mediator.[13]

References[edit]

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000105085 - Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000045248 - Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Ryu S, Zhou S, Ladurner AG, Tjian R (February 1999). "The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1". Nature. 397 (6718): 446–450. Bibcode:1999Natur.397..446R. doi:10.1038/17141. hdl:11858/00-001M-0000-0019-A36A-8. PMID 9989412. S2CID 4405569.
  6. ^ a b "Entrez Gene: CRSP7 cofactor required for Sp1 transcriptional activation, subunit 7, 70kDa".
  7. ^ Takahashi H, Parmely TJ, Sato S, Tomomori-Sato C, Banks CA, Kong SE, et al. (July 2011). "Human mediator subunit MED26 functions as a docking site for transcription elongation factors". Cell. 146 (1): 92–104. doi:10.1016/j.cell.2011.06.005. PMC 3145325. PMID 21729782.
  8. ^ a b Cermakova K, Veverka V, Hodges HC (January 2023). "The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and disorder". Biochemical Society Transactions. 51 (1): 125–135. doi:10.1042/BST20220342. PMC 9987994. PMID 36651856. S2CID 255969299.
  9. ^ Booth V, Koth CM, Edwards AM, Arrowsmith CH (October 2000). "Structure of a conserved domain common to the transcription factors TFIIS, elongin A, and CRSP70". The Journal of Biological Chemistry. 275 (40): 31266–31268. doi:10.1074/jbc.M002595200. PMID 10811649.
  10. ^ a b Ling Y, Smith AJ, Morgan GT (2006). "A sequence motif conserved in diverse nuclear proteins identifies a protein interaction domain utilised for nuclear targeting by human TFIIS". Nucleic Acids Research. 34 (8): 2219–2229. doi:10.1093/nar/gkl239. PMC 1450333. PMID 16648364.
  11. ^ Cermakova K, Demeulemeester J, Lux V, Nedomova M, Goldman SR, Smith EA, et al. (November 2021). "A ubiquitous disordered protein interaction module orchestrates transcription elongation". Science. 374 (6571): 1113–1121. Bibcode:2021Sci...374.1113C. doi:10.1126/science.abe2913. PMC 8943916. PMID 34822292.
  12. ^ a b c d e Sato S, Tomomori-Sato C, Parmely TJ, Florens L, Zybailov B, Swanson SK, et al. (June 2004). "A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology". Molecular Cell. 14 (5): 685–691. doi:10.1016/j.molcel.2004.05.006. PMID 15175163.
  13. ^ Ding N, Tomomori-Sato C, Sato S, Conaway RC, Conaway JW, Boyer TG (January 2009). "MED19 and MED26 are synergistic functional targets of the RE1 silencing transcription factor in epigenetic silencing of neuronal gene expression". The Journal of Biological Chemistry. 284 (5): 2648–2656. doi:10.1074/jbc.M806514200. PMC 2631966. PMID 19049968.
This article incorporates text from the public domain Pfam and InterPro: IPR017923

Further reading[edit]